Filing Flows › Chemed (CHE) › Q3 2026
Chemed (CHE) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 29, 2026
Chemed (CHE) reported revenue of $691M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before. Operating margin was 14.0%, net earnings $71.6M (10.4% of revenue).
Chemed, Q3 2026: revenue $691M (+11% year over year), operating margin 14.0%, net earnings $71.6M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $691M | +3% | +11% |
| Operating profit | $96.4M | +8% | +29% |
| Net earnings | $71.6M | +6% | +12% |
| Operating cash flow | $56.6M | -33% | -32% |
| Free cash flow | $37.9M | -45% | -43% |
What changed
Revenue was $690.9M in Q3 2026, up 11% year over year and up 3% from the previous quarter. VITAS was the largest line at 66% of revenue. VITAS added $49.7M year over year (up 12%), 75% of the total change.
Operating profit was $96.4M, a 14.0% margin (up 2.0 points year over year). Of the extra revenue versus Q3 2025, 33% reached operating profit, above the 12% margin then. Total costs grew 8% against revenue growth of 11%. The fastest-growing cost line was Other operating costs (+30%). Net earnings were $71.6M, up 12% year over year. The effective tax rate was 25.9%.
Operating cash flow was $56.6M (down 32% year over year), 79% of net earnings. Non-cash charges added back $17.4M of depreciation and amortization. Working capital and other items used $32.5M. Capital expenditures of $18.7M left free cash flow of $37.9M.
Questions
What was Chemed's revenue in the third quarter 2026?
Chemed (CHE) reported revenue of $691M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before.
Was Chemed profitable in the third quarter 2026?
Operating profit was $96.4M (14.0% of revenue) and net earnings $71.6M.
Source: Chemed 10-Q on SEC EDGAR.